drugset
drugset / Trial / NCT03738449

The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition

NCT03738449 ↗

Phase 1 Completed 23 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this clinical trial is to evaluate the pharmacokinetics and safety/tolerability after oral administration of CKD-387 and D484 under fed condition in healthy adults.

Timeline

Start
2019-01-08
Primary completion
2019-01-18
Completion
2019-01-24

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-387 Unknown — Oral
Subject D484 Unknown — Oral

Indications

type 2 diabetes mellitus